Terms: = Endocrine gland cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
45 results:
1. brca1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer.
Richau CS; Scherer NM; Matta BP; de Armas EM; de Barros Moreira FC; Bergmann A; Pereira Chaves CB; Boroni M; Dos Santos ACE; Moreira MAM
Cancer Med; 2024 Feb; 13(3):e6729. PubMed ID: 38308422
[TBL] [Abstract] [Full Text] [Related]
2. BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
3. [Application of genetic counseling and preventive surgery in hereditary breast-ovarian cancer syndrome based on a rare family].
Liu SH; Dong L; Li B; Zhao D; Ying JM
Zhonghua Zhong Liu Za Zhi; 2023 Sep; 45(9):796-802. PubMed ID: 37805444
[No Abstract] [Full Text] [Related]
4. Management of patients with advanced epithelial ovarian cancer: a European survey.
Jochum F; Angeles MA; Balaya V; Drouin L; Nikolova T; Mathevet P; Lécuru F; Azais H; Betrian S; Bolze PA; Dabi Y; Kerbage Y; Sanson C; Zaccarini F; Guyon F; Akladios C; Hsu A; Bendifallah S; Deluche E; Guani B
Arch Gynecol Obstet; 2023 Aug; 308(2):535-549. PubMed ID: 36737552
[TBL] [Abstract] [Full Text] [Related]
5. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
[TBL] [Abstract] [Full Text] [Related]
6. Risk reducing surgery with peritoneal staging in brca1-2 mutation carriers. A prospective study.
Marchetti C; Arcieri M; Vertechy L; Ergasti R; Russo G; Zannoni GF; Minucci A; Ercoli A; Scambia G; Fagotti A
Eur J Surg Oncol; 2022 Dec; 48(12):2539-2544. PubMed ID: 35871032
[TBL] [Abstract] [Full Text] [Related]
7. An in-Depth Analysis of Ovarian cancer: Pathogenesis and Clinical Manifestation.
Mahima M; Mahmood T; Ved A; Siddiqui MH; Ahsan F; Shamim A; Ansari VA; Ahmad A; Kashyap MK
Drug Res (Stuttg); 2022 Oct; 72(8):424-434. PubMed ID: 35760337
[TBL] [Abstract] [Full Text] [Related]
8. Detection of brca1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian cancer.
Li L; Chen F; Lin A; Wang D; Shi Y; Chen G
Comput Math Methods Med; 2021; 2021():4854282. PubMed ID: 34721658
[TBL] [Abstract] [Full Text] [Related]
9. [Ductal adenocarcinoma of the pancreas: subtypes and molecular pathology].
Schlitter AM; Konukiewitz B; Kasajima A; Reichert M; Klöppel G
Pathologe; 2021 Sep; 42(5):464-471. PubMed ID: 34402977
[TBL] [Abstract] [Full Text] [Related]
10. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging.
Morani AC; Hanafy AK; Ramani NS; Katabathina VS; Yedururi S; Dasyam AK; Prasad SR
Radiol Imaging Cancer; 2020 Mar; 2(2):e190020. PubMed ID: 33778702
[TBL] [Abstract] [Full Text] [Related]
11. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
Heinze K; Rengsberger M; Gajda M; Jansen L; Osmers L; Oliveira-Ferrer L; Schmalfeldt B; Dürst M; Häfner N; Runnebaum IB
Clin Epigenetics; 2021 Jan; 13(1):15. PubMed ID: 33482905
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.
Arif AA; Kim PTW; Melck A; Churg A; Schwartz Z; Stuart HC
Am J Case Rep; 2021 Jan; 22():e927761. PubMed ID: 33452231
[TBL] [Abstract] [Full Text] [Related]
13. Effect of Germline Mutations in Homologous Recombination Repair Genes on Overall Survival of Patients with Pancreatic Adenocarcinoma.
Yadav S; Kasi PM; Bamlet WR; Ho TP; Polley EC; Hu C; Hart SN; Rabe KG; Boddicker NJ; Gnanaolivu RD; Lee KY; Lindstrom TH; Petersen GM; Couch FJ; McWilliams RR
Clin Cancer Res; 2020 Dec; 26(24):6505-6512. PubMed ID: 33028596
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics of thyroid cancer in Manizales, Colombia, 2008-2015.
Arias-Ortiz NE; Guzmán-Gallego EA
Rev Peru Med Exp Salud Publica; 2020; 37(2):287-291. PubMed ID: 32876219
[TBL] [Abstract] [Full Text] [Related]
15. How I treat pancreatic cancer.
Taieb J; Abdallah R
ESMO Open; 2020 Aug; 4(Suppl 2):e000818. PubMed ID: 32817138
[TBL] [Abstract] [Full Text] [Related]
16. Pancreatic cancer.
Mizrahi JD; Surana R; Valle JW; Shroff RT
Lancet; 2020 Jun; 395(10242):2008-2020. PubMed ID: 32593337
[TBL] [Abstract] [Full Text] [Related]
17. Association of expression of p53, livin, ERCC1, brca1 and PARP1 in epithelial ovarian cancer tissue with drug resistance and prognosis.
Zhang Z; Dou X; Yang H; Jia L; Qin K; Gao X; Yang B; Zhang W; Qin C; Zhang F; Shan B
Pathol Res Pract; 2020 Feb; 216(2):152794. PubMed ID: 31902551
[TBL] [Abstract] [Full Text] [Related]
18. Outcome and Prognostic Impact of Surgical staging in Serous Tubal Intraepithelial Carcinoma: A Cohort Study and Systematic Review.
Van der Hoeven NMA; Van Wijk K; Bonfrer SE; Beltman JJ; Louwe LA; De Kroon CD; Van Asperen CJ; Gaarenstroom KN
Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):463-471. PubMed ID: 29691126
[TBL] [Abstract] [Full Text] [Related]
19. Predictive Effect of the Total Number of Examined Lymph Nodes on N staging and Survival in Pancreatic Neuroendocrine Neoplasms.
Zhang X; Lu L; Liu P; Cao F; Wei Y; Ma L; Gong P
Pancreas; 2018 Feb; 47(2):183-189. PubMed ID: 29329160
[TBL] [Abstract] [Full Text] [Related]
20. Changes in classification of genetic variants in brca1 and BRCA2.
Kast K; Wimberger P; Arnold N
Arch Gynecol Obstet; 2018 Feb; 297(2):279-280. PubMed ID: 29302806
[TBL] [Abstract] [Full Text] [Related]
[Next]